{"id":"W1981890973","doi":"10.1158/1538-7445.am2013-863","title":"Abstract 863: Inhibition of breast cancer metastaticprogression by a novel uPAR targeted monoclonal antibody, ATN-658, correlateswith the uPAR expression.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre; Concordia University; McGill University","funders":"","keywords":"Urokinase receptor; Medicine; Cancer research; Metastasis; Breast cancer; Cancer; Metastatic breast cancer; Pathology; Trastuzumab; Monoclonal antibody; Sunitinib; Triple-negative breast cancer; Antibody; Plasminogen activator; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009605761,0.0003447684,0.000263939,0.0001858279,0.0001434417,0.0001745645,0.0002206316,0.0002403727,0.002646567],"category_scores_gemma":[0.00006011594,0.0001098137,0.000248588,0.000206557,0.0001101834,0.0001152345,0.0001068273,0.0006185083,0.0006330787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003024346,"about_ca_system_score_gemma":0.0002279161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009340927,"about_ca_topic_score_gemma":0.001440985,"domain_scores_codex":[0.9998965,0.00001409061,0.000008522338,0.00001741135,0.00003365755,0.00002988085],"domain_scores_gemma":[0.9999655,0.000004146247,0.000007984407,0.000003777874,0.0000062599,0.00001219927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003172735,0.0002130411,0.0001865672,0.00005562042,0.00001230868,0.0000381024,0.000006757775,0.00009027595,0.9947067,0.00008677316,0.0004893309,0.003797187],"study_design_scores_gemma":[0.0001121131,0.001605119,0.004883112,0.000006825317,0.0000311809,0.0003368915,0.00001000181,0.0009475427,0.9886503,0.00002553678,0.0033865,0.000004813508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879872,0.002649598,0.002192295,0.0003114401,0.0001275515,0.0001031229,0.00116808,0.0002068672,0.005253792],"genre_scores_gemma":[0.9867898,0.001338573,0.002638246,0.0001462963,0.00002597659,0.0001031653,0.001901507,0.00002400562,0.007032421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002646567,"threshold_uncertainty_score":0.008853614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02937615621148989,"score_gpt":0.3823368335965681,"score_spread":0.3529606773850782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}